Lobbying activity
Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 190 filings
Top spenders & firms Spend by issue Political contributions Revolving door
Q1
FAEGRE DRINKER BIDDLE & REATH LLP for EVERYLIFE FOUNDATION FOR RARE DISEASES
Q1
NATIONAL ALLIANCE ON MENTAL ILLNESS for NATIONAL ALLIANCE ON MENTAL ILLNESS
Q1
ALLIANCE FOR REGENERATIVE MEDICINE for ALLIANCE FOR REGENERATIVE MEDICINE
Q1
ASSOCIATION FOR CLINICAL ONCOLOGY for ASSOCIATION FOR CLINICAL ONCOLOGY
Q1
KOUNTOUPES DENHAM CARR & REID, LLC for BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY)
Q1
CURE SMA for CURE SMA
2A
ORCHARD THERAPEUTICS NORTH AMERICA for ORCHARD THERAPEUTICS NORTH AMERICA
Q4
AMERICAN ACADEMY OF PEDIATRICS for AMERICAN ACADEMY OF PEDIATRICS
Q4
AMERICAN HEART ASSOCIATION for AMERICAN HEART ASSOCIATION
4A
DANA-FARBER CANCER INSTITUTE for DANA-FARBER CANCER INSTITUTE
Q4
CHILDREN'S HOSPITAL BOSTON for CHILDREN'S HOSPITAL BOSTON
Q4
CYSTIC FIBROSIS FOUNDATION for CYSTIC FIBROSIS FOUNDATION
Q4
BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.
Q4
ALLIANCE FOR REGENERATIVE MEDICINE for ALLIANCE FOR REGENERATIVE MEDICINE
Q4
EPILEPSY FOUNDATION for EPILEPSY FOUNDATION
Q4
NATIONAL ALLIANCE ON MENTAL ILLNESS for NATIONAL ALLIANCE ON MENTAL ILLNESS
Q4
ORCHARD THERAPEUTICS NORTH AMERICA for ORCHARD THERAPEUTICS NORTH AMERICA
Q4
NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES for NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)
4T
AVENUE SOLUTIONS for ALLIANCE FOR REGENERATIVE MEDICINE
Q4
TEXAS CHILDREN'S HOSPITAL for TEXAS CHILDREN'S HOSPITAL
Q4
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
Q4
NATIONAL MULTIPLE SCLEROSIS SOCIETY for NATIONAL MULTIPLE SCLEROSIS SOCIETY
Q4
DANA-FARBER CANCER INSTITUTE for DANA-FARBER CANCER INSTITUTE
Q4
ASSOCIATION FOR CLINICAL ONCOLOGY for ASSOCIATION FOR CLINICAL ONCOLOGY
Q4
TERUMO BCT, INC. for TERUMO BCT, INC.